Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FJH0P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,367
Award facts
- Contract value 100% obligated
- $16,367.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,367.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors on January 9, 2026, with a completion date of January 12, 2026. This non-set-aside award was issued as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which serves as the parent organization and holds the underlying DLA IDC through December 31, 2031.
ENBREL is a biologic immunosuppressant medication used primarily to treat rheumatoid arthritis, psoriasis, and other inflammatory conditions. This delivery order reflects the Defense Logistics Agency's procurement of specialty pharmaceutical products to support military healthcare programs worldwide, including military treatment facilities and veterans' healthcare systems. AmerisourceBergen's status as a major pharmaceutical distributor and critical federal medical vendor demonstrates its capability to supply brand-name specialty medications and medical devices through competitively awarded contracts to support the Department of Defense's healthcare mission.
Quick answers
Who was awarded contract SPE2DR26FJH0P?
SPE2DR26FJH0P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FJH0P worth?
The government has obligated $16,367 on SPE2DR26FJH0P.
Is contract SPE2DR26FJH0P an order under another contract?
Yes. SPE2DR26FJH0P is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH0P competed?
The extent of competition for SPE2DR26FJH0P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award